ID
37132
Beskrivning
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Nyckelord
Versioner (1)
- 2019-07-03 2019-07-03 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
3 juli 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Patient Log
- StudyEvent: ODM
Beskrivning
Patient Log
Alias
- UMLS CUI-1
- C0030705
- UMLS CUI-2
- C1708728
Beskrivning
Investigator Name
Datatyp
text
Alias
- UMLS CUI [1]
- C2826892
Beskrivning
Person Initials
Datatyp
text
Alias
- UMLS CUI [1]
- C2986440
Beskrivning
Interview, Date in time
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0021822
- UMLS CUI [1,2]
- C0011008
Beskrivning
Exclusion, Reason and Justification
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2828389
- UMLS CUI [1,2]
- C0566251
Similar models
Patient Log
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])